Expected Impact of Biosimilars on the Pharmaceutical Companies

Detalles Bibliográficos
Autores principales: Golshani, Shiva, Ali Faramarzi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shiraz University of Medical Sciences 2021
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438344/
https://www.ncbi.nlm.nih.gov/pubmed/34539015
http://dx.doi.org/10.30476/IJMS.2021.92314.2356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438344/
https://www.ncbi.nlm.nih.gov/pubmed/34539015
http://dx.doi.org/10.30476/IJMS.2021.92314.2356

Ejemplares similares